HBP Share Price

Open 1.36 Change Price %
High 1.46 1 Day -0.02 -1.35
Low 1.36 1 Week 0.14 10.61
Close 1.46 1 Month 0.21 16.80
Volume 1700 1 Year -0.45 -23.56
52 Week High 2.25
52 Week Low 1.20
HBP Important Levels
Resistance 2 1.55
Resistance 1 1.51
Pivot 1.43
Support 1 1.41
Support 2 1.37
TSE Canada Most Active Stocks
BIN 41.40 -1.62%
BIN 41.40 -1.62%
LSG 2.08 8.33%
LSG 2.08 8.33%
LSG 2.08 8.33%
TBE 0.03 0.00%
SC 60.83 -0.44%
PRE 0.64 0.00%
PRE 0.64 0.00%
PRE 0.64 0.00%
More..
TSE Canada Top Gainers Stocks
CUR 0.02 100.00%
CUR 0.02 100.00%
CUR 0.02 100.00%
TVI 0.02 100.00%
CUM 0.90 13.92%
CUM 0.90 13.92%
GVC 0.81 10.96%
GVC 0.81 10.96%
LSG 2.08 8.33%
LSG 2.08 8.33%
More..
TSE Canada Top Losers Stocks
GBV 0.46 -24.59%
CTU-A 0.19 -9.52%
QEC 0.80 -8.05%
QEC 0.80 -8.05%
SJ 39.41 -7.68%
LUN 7.65 -7.50%
LUN 7.65 -7.50%
TBL 1.01 -7.34%
ORT 0.26 -7.14%
ORT 0.26 -7.14%
More..

Helix BioPharma Corp (TSE: HBP)

HBP Technical Analysis 3
As on 16th Jan 2017 HBP Share Price closed @ 1.46 and we RECOMMEND Sell for LONG-TERM with Stoploss of 1.85 & Sell for SHORT-TERM with Stoploss of 1.54 we also expect STOCK to react on Following IMPORTANT LEVELS.
HBP Target for January
1st Target up-side N/A
2nd Target up-side N/A
3rd Target up-side N/A
1st Target down-side N/A
2nd Target down-side N/A
3rd Target down-side N/A
HBP Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.helixbiopharma.com
HBP Address
HBP
305 Industrial Parkway South
Unit 3
Aurora, ON L4G 6X7
Canada
Phone: 905-841-2300
Fax: 905-841-2244
HBP Latest News
Helix BioPharma Corp. Announces Additional Private Placement Closing   MarketWatch   - 30th Dec 16
Helix BioPharma Corp. Successfully Out-Licenses Late Stage Biphasix Technology   Marketwired (press release)   - 23rd Dec 16
Helix Biopharma reports 1Q loss   Yahoo News   - 14th Dec 16
Helix BioPharma Corp. Announces Fiscal First Quarter 2017 Results   Marketwired (press release)   - 14th Dec 16
Helix BioPharma Corp. Presents Topline L-DOS47 Results at the 17th IASCLC ...   Marketwired (press release)   - 06th Dec 16
Helix BioPharma Corp. Announces Fiscal 2016 Results   Marketwired (press release)   - 01st Nov 16
Helix BioPharma Corp. Announces New Director Appointment   Marketwired (press release)   - 07th Sep 16
Helix BioPharma Corp. Opens the Market   MarketWatch   - 26th May 16
Helix BioPharma Corp. Announces CEO Change   Marketwired (press release)   - 30th Mar 16
Helix BioPharma Corp. Announces Fiscal 2015 Results   Marketwired (press release)   - 30th Oct 15
Interactive Technical Analysis Chart Helix BioPharma Corp ( HBP TSE Canada )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Helix BioPharma Corp
HBP Business Profile
Helix BioPharma Corp., a biopharmaceutical company, develops drugs for the prevention and treatment of cancer based on its proprietary technologies. The company focuses on the development of L-DOS47 that is in phase I/II clinical trial for the treatment of inoperable, locally advanced, and recurrent or metastatic non-small cell lung cancer; and Topical Interferon Alpha-2b, which has completed phase II study for the treatment of low-grade cervical lesions and ano-genital warts caused by human papilloma virus infections. It also offers DOS47, a patented oncology platform technology that derives a therapeutic pharmacological effect by acting upon a naturally occurring substance in the body. Helix BioPharma Corp. is based in Aurora, Canada.